Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease

BACKGROUND: There are several treatment modalities for unresectable neuroendocrine tumors. Traditionally, the aim of these treatments has been to reduce the tumor load; referred to as objective response (OR). Less emphasis has been put on inducing the tumors to stop growing without a reduction in to...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiis-Evensen, Espen, Poole, Amalie Christine, Nguyen, Hong-Thien Thi, Sponheim, Jon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247237/
https://www.ncbi.nlm.nih.gov/pubmed/32448245
http://dx.doi.org/10.1186/s12885-020-06963-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247237/
https://www.ncbi.nlm.nih.gov/pubmed/32448245
http://dx.doi.org/10.1186/s12885-020-06963-6

Ejemplares similares